Weiss Multi-Strategy Advisers’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,452
Closed -$141K 882
2020
Q4
$141K Sell
10,452
-726
-6% -$8.77K ﹤0.01% 659
2020
Q3
$132K Buy
11,178
+124
+1% +$1.51K ﹤0.01% 538
2020
Q2
$163K Buy
+11,054
New +$164K ﹤0.01% 523
2020
Q1
Sell
-10,500
Closed -$254K 671
2019
Q4
$254K Sell
10,500
-9,500
-48% -$197K ﹤0.01% 568
2019
Q3
$384K Hold
20,000
0.01% 509
2019
Q2
$591K Sell
20,000
-15,000
-43% -$578K 0.02% 413
2019
Q1
$1.66M Sell
35,000
-5,000
-13% -$220K 0.04% 349
2018
Q4
$1.44M Buy
40,000
+9,882
+33% +$464K 0.06% 258
2018
Q3
$1.85M Sell
30,118
-4,882
-14% -$314K 0.05% 335
2018
Q2
$2.36M Sell
35,000
-10,000
-22% -$560K 0.06% 323
2018
Q1
$2.44M Sell
45,000
-10,000
-18% -$559K 0.08% 295
2017
Q4
$3.29M Buy
55,000
+5,000
+10% +$303K 0.08% 260
2017
Q3
$2.43M Hold
50,000
0.09% 280
2017
Q2
$2.63M Sell
50,000
-16,000
-24% -$745K 0.11% 247
2017
Q1
$2.99M Hold
66,000
0.12% 210
2016
Q4
$2.5M Buy
66,000
+16,000
+32% +$605K 0.12% 175
2016
Q3
$1.89M Buy
+50,000
New +$1.1M 0.12% 225
2015
Q2
Sell
-10,000
Closed -$313K 553
2015
Q1
$313K Buy
+10,000
New +$290K 0.01% 396

Other funds holding AERI

Weiss Multi-Strategy Advisers's AERI Position: Q1 2021 in Review

Weiss Multi-Strategy Advisers sold out of Aerie Pharmaceuticals (AERI) in Q1 2021, closing a stake of 10,452 shares — an estimated $141K sold.

Weiss Multi-Strategy Advisers first reported a position in AERI in Q1 2015 and held it in 18 quarters. The position peaked at $3.29M in Q4 2017. 158 funds tracked by Wall St. Rank hold AERI as of Q1 2021.

  • Weiss Multi-Strategy Advisers reported no remaining Aerie Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 10,452 Aerie Pharmaceuticals shares in Q1 2021, an estimated $141K.
  • Weiss Multi-Strategy Advisers first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 18 quarters.
  • Weiss Multi-Strategy Advisers's Aerie Pharmaceuticals position peaked at $3.29M in Q4 2017.
  • 158 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2021, filed 14 May 2021.